| Alpha 1 antitrypsin is an inhibitor of the SARS-CoV-2–Priming protease TMPRSS2 NP Azouz, AM Klingler, V Callahan, IV Akhrymuk, K Elez, L Raich, ... Pathogens and Immunity 6 (1), 55, 2021 | 106 | 2021 |
| A novel approach for Hepatocellular Carcinoma detection and classification based on triphasic CT Protocol V Bevilacqua, A Brunetti, GF Trotta, G Dimauro, K Elez, V Alberotanza, ... 2017 IEEE Congress on Evolutionary Computation (CEC), 1856-1863, 2017 | 32 | 2017 |
| PRODIGY-crystal: a web-tool for classification of biological interfaces in protein complexes B Jiménez-García, K Elez, PI Koukos, AM Bonvin, A Vangone Bioinformatics 35 (22), 4821-4823, 2019 | 28 | 2019 |
| Distinguishing crystallographic from biological interfaces in protein complexes: role of intermolecular contacts and energetics for classification K Elez, AMJJ Bonvin, A Vangone BMC bioinformatics 19, 19-28, 2018 | 26 | 2018 |
| Biological vs. Crystallographic Protein Interfaces: An Overview of Computational Approaches for Their Classification K Elez, AMJJ Bonvin, A Vangone Crystals 10 (2), 114, 2020 | 19 | 2020 |
| Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties T Hempel, K Elez, N Krüger, L Raich, JH Shrimp, O Danov, D Jonigk, ... Chemical Science 12 (38), 12600-12609, 2021 | 14 | 2021 |
| A community effort in SARS-CoV-2 drug discovery J Schimunek, P Seidl, K Elez, T Hempel, T Le, F Noé, S Olsson, L Raich, ... Molecular informatics, 2023 | 2 | 2023 |
| Bioinforming M Anteghini, K Elez, S Bandstra, R Lamba, L Paladin BioHackrXiv, 2023 | | 2023 |
| Pharmaceutical composition for treating COVID-19 comprising Otamixaban and at least one of Camostat and Nafamostat T Hempel, K Elez, L Raich, F Noé, N Krüger, M Hoffmann, S Pöhlmann EP Patent App. EP4122461A1, 2023 | | 2023 |
